HealthTech 2026: Innovation, Prevention & the Future of Health

Rebecca is a corporate commercial lawyer specialising in the health sector.  Her clients include NHS organisations and other health and social care providers in the North West and nationally. Rebecca has been the operational lead lawyer on several major NHS transformation projects including mergers between NHS trusts / foundation trusts and the establishment of integrated care systems. Rebecca joined Browne Jacobson in 2019 and has previously worked in-house at NHS Improvement / Monitor, the Care Quality Commission and the Government Legal Department.  Rebecca was named “Lawyer of the Year” at the Made in Manchester Awards 2023.

Adam Dustagheer is CEO and Founder of Datnexa, an AI and digital transformation partner helping public-service organisations turn data and technology into practical, measurable outcomes. With more than 20 years’ experience across government, healthcare, regulation and the third sector, he specialises in responsible, people-centred AI adoption. Adam’s work focuses on applying AI to real-world challenges – supporting prevention, improving services and helping organisations build the confidence, capability and governance needed to scale innovation safely.

Shainoor (Shain) Khoja is a physiotherapist, social-impact entrepreneur and Founder & CEO of Thriving.ai. Drawing on more than 25 years working across health and social impact, alongside her own experience of caring for ageing family members, Shain is passionate about rethinking how we support people beyond traditional healthcare settings. Thriving.ai connects individuals, families, community organisations and care teams, using everyday health, wellbeing and home-based insights to support more proactive, personalised care. Her current focus is on how neighbourhood health can connect the signals, people and services around an individual to enable earlier support and healthier, more independent lives.

Claire Williams is Head of Pharmacovigilance and Regulatory Services at NorthWest EHealth and an expert in real-world safety monitoring. Having worked with NWEH since the landmark Salford Lung Studies, Claire has helped develop technology-enabled pharmacovigilance across large pragmatic clinical trials, using routinely collected healthcare and trial data to identify potential safety events earlier. She works closely with technical and clinical teams to develop innovative approaches that move safety monitoring from reactive reporting towards proactive, real-time surveillance. Claire holds an MSc in Pharmacovigilance, chairs the Greater Manchester Central Research Ethics Committee, and is a passionate advocate for inclusive research and women’s health.

My group’s work is focused on the development and evaluation of imaging biomarkers for breast cancer risk prediction and early detection, and the science underpinning stratified screening. Our research encompasses a range of technologies both for breast density measurement and early detection of cancer. Recent projects include developing AI for risk prediction from standard and ultra-low-dose mammograms, evaluation of the impact of computer aided detection on reader behaviour and performance, reader variability studies, developing fair and explainable AI, predicting breast cancer subtypes, and the use of contrast enhanced mammography for evaluation of breast lesions. Our research is collaborative within a multidisciplinary network of scientists and clinicians in the UK and overseas.

I am Deputy Director for Strategy & System Development for the Greater Manchester Health and Social Care Partnership. The Partnership works on behalf of all of the health and social care organisations in Greater Manchester.

My role involves leading strategy and policy development within GM devolution, working closely with the Combined Authority, as well as leading transformation programmes such as on the establishment of Local Care Organisations (LCOs) in GM. I have previously worked in a range of strategy, transformation and commissioning roles in Greater Manchester and the North West.

Daniel Zamora is Programme Director at Health Innovation Manchester responsible for the delivery of large scale partnership triple-helix programmes in Greater Manchester and Innovator Support services.  He has previously led NHS Business Support Programmes, part-funded by the European Regional Development Fund across Cheshire East and Greater Manchester, aimed at supporting Small and Medium Enterprises SMEs. Daniel worked for 25+ years in healthcare and spent his last 15 years in research an innovation positions within the NHS.

Daniel started his career with Alcon Laboratories working across marketing, sales, business development and customer services, leading teams to develop both the Pharmaceutical and Medical Device business units. Daniel moved to the UK in 2008 to study an MBA at Manchester Business School and since then has held several senior management positions supporting NHS and University organisations, such as North West e-Health, Trustech, Manchester University NHS Foundation Trust and currently Health Innovation Manchester. He is also committee member for the HIMSS UK and Ireland community.

Azra Zia is the Health Inclusion and Community Engagement Manager at Prevent Breast Cancer, working to improve breast health equity for women from ethnically diverse and socially disadvantaged communities across Greater Manchester. Working with NHS partners and trusted grassroots organisations, she develops culturally relevant approaches to raising awareness of breast cancer prevention and early diagnosis. Azra believes communities are not “hard to reach” but often under-served by traditional health messaging. She is passionate about ensuring women have the information and support needed to make informed decisions about their breast health and welcomes neighbourhood solutions that improve access and build trust.

Head of Innovation – Bruntwood SciTech – Development of the life sciences, digital and technology ecosystem across the Bruntwood SciTech portfolio in the North West.

 Applying my experiences gained from>20 years across pharmaceutical drug discovery and development. My mission is to drive the success of companies across the Bruntwood SciTech portfolio by ensuring the physical spaces, connections and events encourage growth, and reducing the barriers for start ups to take great ideas into action.